Copyright Reports & Markets. All rights reserved.

Global Recombinant Human Interleukin-2 Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Recombinant Human Interleukin-2 Consumption Value by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Pharmaceutical Grade
    • 1.3.3 Other
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Recombinant Human Interleukin-2 Consumption Value by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Medical
    • 1.4.3 Culture Medium Supplement
    • 1.4.4 Scientific Research
  • 1.5 Global Recombinant Human Interleukin-2 Market Size & Forecast
    • 1.5.1 Global Recombinant Human Interleukin-2 Consumption Value (2019 & 2023 & 2030)
    • 1.5.2 Global Recombinant Human Interleukin-2 Sales Quantity (2019-2030)
    • 1.5.3 Global Recombinant Human Interleukin-2 Average Price (2019-2030)

2 Manufacturers Profiles

  • 2.1 Cytiva
    • 2.1.1 Cytiva Details
    • 2.1.2 Cytiva Major Business
    • 2.1.3 Cytiva Recombinant Human Interleukin-2 Product and Services
    • 2.1.4 Cytiva Recombinant Human Interleukin-2 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Cytiva Recent Developments/Updates
  • 2.2 Bio-Techne
    • 2.2.1 Bio-Techne Details
    • 2.2.2 Bio-Techne Major Business
    • 2.2.3 Bio-Techne Recombinant Human Interleukin-2 Product and Services
    • 2.2.4 Bio-Techne Recombinant Human Interleukin-2 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Bio-Techne Recent Developments/Updates
  • 2.3 Lonza
    • 2.3.1 Lonza Details
    • 2.3.2 Lonza Major Business
    • 2.3.3 Lonza Recombinant Human Interleukin-2 Product and Services
    • 2.3.4 Lonza Recombinant Human Interleukin-2 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Lonza Recent Developments/Updates
  • 2.4 Sartorius CellGenix
    • 2.4.1 Sartorius CellGenix Details
    • 2.4.2 Sartorius CellGenix Major Business
    • 2.4.3 Sartorius CellGenix Recombinant Human Interleukin-2 Product and Services
    • 2.4.4 Sartorius CellGenix Recombinant Human Interleukin-2 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Sartorius CellGenix Recent Developments/Updates
  • 2.5 Thermo Fisher Scientific
    • 2.5.1 Thermo Fisher Scientific Details
    • 2.5.2 Thermo Fisher Scientific Major Business
    • 2.5.3 Thermo Fisher Scientific Recombinant Human Interleukin-2 Product and Services
    • 2.5.4 Thermo Fisher Scientific Recombinant Human Interleukin-2 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Thermo Fisher Scientific Recent Developments/Updates
  • 2.6 Miltenyi Biotec
    • 2.6.1 Miltenyi Biotec Details
    • 2.6.2 Miltenyi Biotec Major Business
    • 2.6.3 Miltenyi Biotec Recombinant Human Interleukin-2 Product and Services
    • 2.6.4 Miltenyi Biotec Recombinant Human Interleukin-2 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Miltenyi Biotec Recent Developments/Updates
  • 2.7 Akron Biotech
    • 2.7.1 Akron Biotech Details
    • 2.7.2 Akron Biotech Major Business
    • 2.7.3 Akron Biotech Recombinant Human Interleukin-2 Product and Services
    • 2.7.4 Akron Biotech Recombinant Human Interleukin-2 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Akron Biotech Recent Developments/Updates
  • 2.8 Sino Biological
    • 2.8.1 Sino Biological Details
    • 2.8.2 Sino Biological Major Business
    • 2.8.3 Sino Biological Recombinant Human Interleukin-2 Product and Services
    • 2.8.4 Sino Biological Recombinant Human Interleukin-2 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Sino Biological Recent Developments/Updates
  • 2.9 Creative Bioarray
    • 2.9.1 Creative Bioarray Details
    • 2.9.2 Creative Bioarray Major Business
    • 2.9.3 Creative Bioarray Recombinant Human Interleukin-2 Product and Services
    • 2.9.4 Creative Bioarray Recombinant Human Interleukin-2 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Creative Bioarray Recent Developments/Updates

3 Competitive Environment: Recombinant Human Interleukin-2 by Manufacturer

  • 3.1 Global Recombinant Human Interleukin-2 Sales Quantity by Manufacturer (2019-2024)
  • 3.2 Global Recombinant Human Interleukin-2 Revenue by Manufacturer (2019-2024)
  • 3.3 Global Recombinant Human Interleukin-2 Average Price by Manufacturer (2019-2024)
  • 3.4 Market Share Analysis (2023)
    • 3.4.1 Producer Shipments of Recombinant Human Interleukin-2 by Manufacturer Revenue ($MM) and Market Share (%): 2023
    • 3.4.2 Top 3 Recombinant Human Interleukin-2 Manufacturer Market Share in 2023
    • 3.4.3 Top 6 Recombinant Human Interleukin-2 Manufacturer Market Share in 2023
  • 3.5 Recombinant Human Interleukin-2 Market: Overall Company Footprint Analysis
    • 3.5.1 Recombinant Human Interleukin-2 Market: Region Footprint
    • 3.5.2 Recombinant Human Interleukin-2 Market: Company Product Type Footprint
    • 3.5.3 Recombinant Human Interleukin-2 Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Recombinant Human Interleukin-2 Market Size by Region
    • 4.1.1 Global Recombinant Human Interleukin-2 Sales Quantity by Region (2019-2030)
    • 4.1.2 Global Recombinant Human Interleukin-2 Consumption Value by Region (2019-2030)
    • 4.1.3 Global Recombinant Human Interleukin-2 Average Price by Region (2019-2030)
  • 4.2 North America Recombinant Human Interleukin-2 Consumption Value (2019-2030)
  • 4.3 Europe Recombinant Human Interleukin-2 Consumption Value (2019-2030)
  • 4.4 Asia-Pacific Recombinant Human Interleukin-2 Consumption Value (2019-2030)
  • 4.5 South America Recombinant Human Interleukin-2 Consumption Value (2019-2030)
  • 4.6 Middle East & Africa Recombinant Human Interleukin-2 Consumption Value (2019-2030)

5 Market Segment by Type

  • 5.1 Global Recombinant Human Interleukin-2 Sales Quantity by Type (2019-2030)
  • 5.2 Global Recombinant Human Interleukin-2 Consumption Value by Type (2019-2030)
  • 5.3 Global Recombinant Human Interleukin-2 Average Price by Type (2019-2030)

6 Market Segment by Application

  • 6.1 Global Recombinant Human Interleukin-2 Sales Quantity by Application (2019-2030)
  • 6.2 Global Recombinant Human Interleukin-2 Consumption Value by Application (2019-2030)
  • 6.3 Global Recombinant Human Interleukin-2 Average Price by Application (2019-2030)

7 North America

  • 7.1 North America Recombinant Human Interleukin-2 Sales Quantity by Type (2019-2030)
  • 7.2 North America Recombinant Human Interleukin-2 Sales Quantity by Application (2019-2030)
  • 7.3 North America Recombinant Human Interleukin-2 Market Size by Country
    • 7.3.1 North America Recombinant Human Interleukin-2 Sales Quantity by Country (2019-2030)
    • 7.3.2 North America Recombinant Human Interleukin-2 Consumption Value by Country (2019-2030)
    • 7.3.3 United States Market Size and Forecast (2019-2030)
    • 7.3.4 Canada Market Size and Forecast (2019-2030)
    • 7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

  • 8.1 Europe Recombinant Human Interleukin-2 Sales Quantity by Type (2019-2030)
  • 8.2 Europe Recombinant Human Interleukin-2 Sales Quantity by Application (2019-2030)
  • 8.3 Europe Recombinant Human Interleukin-2 Market Size by Country
    • 8.3.1 Europe Recombinant Human Interleukin-2 Sales Quantity by Country (2019-2030)
    • 8.3.2 Europe Recombinant Human Interleukin-2 Consumption Value by Country (2019-2030)
    • 8.3.3 Germany Market Size and Forecast (2019-2030)
    • 8.3.4 France Market Size and Forecast (2019-2030)
    • 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
    • 8.3.6 Russia Market Size and Forecast (2019-2030)
    • 8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

  • 9.1 Asia-Pacific Recombinant Human Interleukin-2 Sales Quantity by Type (2019-2030)
  • 9.2 Asia-Pacific Recombinant Human Interleukin-2 Sales Quantity by Application (2019-2030)
  • 9.3 Asia-Pacific Recombinant Human Interleukin-2 Market Size by Region
    • 9.3.1 Asia-Pacific Recombinant Human Interleukin-2 Sales Quantity by Region (2019-2030)
    • 9.3.2 Asia-Pacific Recombinant Human Interleukin-2 Consumption Value by Region (2019-2030)
    • 9.3.3 China Market Size and Forecast (2019-2030)
    • 9.3.4 Japan Market Size and Forecast (2019-2030)
    • 9.3.5 South Korea Market Size and Forecast (2019-2030)
    • 9.3.6 India Market Size and Forecast (2019-2030)
    • 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
    • 9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

  • 10.1 South America Recombinant Human Interleukin-2 Sales Quantity by Type (2019-2030)
  • 10.2 South America Recombinant Human Interleukin-2 Sales Quantity by Application (2019-2030)
  • 10.3 South America Recombinant Human Interleukin-2 Market Size by Country
    • 10.3.1 South America Recombinant Human Interleukin-2 Sales Quantity by Country (2019-2030)
    • 10.3.2 South America Recombinant Human Interleukin-2 Consumption Value by Country (2019-2030)
    • 10.3.3 Brazil Market Size and Forecast (2019-2030)
    • 10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

  • 11.1 Middle East & Africa Recombinant Human Interleukin-2 Sales Quantity by Type (2019-2030)
  • 11.2 Middle East & Africa Recombinant Human Interleukin-2 Sales Quantity by Application (2019-2030)
  • 11.3 Middle East & Africa Recombinant Human Interleukin-2 Market Size by Country
    • 11.3.1 Middle East & Africa Recombinant Human Interleukin-2 Sales Quantity by Country (2019-2030)
    • 11.3.2 Middle East & Africa Recombinant Human Interleukin-2 Consumption Value by Country (2019-2030)
    • 11.3.3 Turkey Market Size and Forecast (2019-2030)
    • 11.3.4 Egypt Market Size and Forecast (2019-2030)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
    • 11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

  • 12.1 Recombinant Human Interleukin-2 Market Drivers
  • 12.2 Recombinant Human Interleukin-2 Market Restraints
  • 12.3 Recombinant Human Interleukin-2 Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Recombinant Human Interleukin-2 and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Recombinant Human Interleukin-2
  • 13.3 Recombinant Human Interleukin-2 Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Recombinant Human Interleukin-2 Typical Distributors
  • 14.3 Recombinant Human Interleukin-2 Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Recombinant Human Interleukin-2 (IL-2) is a therapeutic protein used in medicine, particularly in immunotherapy. Interleukin-2 is a naturally occurring cytokine produced by activated T cells, and it plays a crucial role in regulating the immune response. Recombinant IL-2 is produced through genetic engineering techniques, where the IL-2 gene is inserted into host cells (such as bacteria, yeast, or mammalian cells) to produce large quantities of the protein.
    According to our (Global Info Research) latest study, the global Recombinant Human Interleukin-2 market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.
    This report is a detailed and comprehensive analysis for global Recombinant Human Interleukin-2 market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
    Key Features:
    Global Recombinant Human Interleukin-2 market size and forecasts, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/g), 2019-2030
    Global Recombinant Human Interleukin-2 market size and forecasts by region and country, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/g), 2019-2030
    Global Recombinant Human Interleukin-2 market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/g), 2019-2030
    Global Recombinant Human Interleukin-2 market shares of main players, shipments in revenue ($ Million), sales quantity (kg), and ASP (US$/g), 2019-2024
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Recombinant Human Interleukin-2
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Recombinant Human Interleukin-2 market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Cytiva, Bio-Techne, Lonza, Sartorius CellGenix, Thermo Fisher Scientific, Miltenyi Biotec, Akron Biotech, Sino Biological, Creative Bioarray, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Recombinant Human Interleukin-2 market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Pharmaceutical Grade
    Other
    Market segment by Application
    Medical
    Culture Medium Supplement
    Scientific Research
    Major players covered
    Cytiva
    Bio-Techne
    Lonza
    Sartorius CellGenix
    Thermo Fisher Scientific
    Miltenyi Biotec
    Akron Biotech
    Sino Biological
    Creative Bioarray
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Recombinant Human Interleukin-2 product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Recombinant Human Interleukin-2, with price, sales quantity, revenue, and global market share of Recombinant Human Interleukin-2 from 2019 to 2024.
    Chapter 3, the Recombinant Human Interleukin-2 competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Recombinant Human Interleukin-2 breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Recombinant Human Interleukin-2 market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Recombinant Human Interleukin-2.
    Chapter 14 and 15, to describe Recombinant Human Interleukin-2 sales channel, distributors, customers, research findings and conclusion.

    Buy now